Flinders Medical Centre Senior Consultant, Dr Anand Rose, has received a Southern Adelaide Local Health Network (SALHN) Enquiry Grant for research into a novel blood test which could be used to monitor the treatment of lung cancer – the most common cause of cancer-related death in Australia.  

This research is one of 23 exciting new research projects to share in the $1 million SALHN Enquiry Grant round, thanks to your generous support, and a collaboration between Flinders Foundation and The Hospital Research Foundation Group.

“Of the cancers in the body, advanced lung cancer is one of the most difficult to treat,” Dr Rose says.

“This blood test could be a useful addition in the doctor’s toolkit to determine if the cancer treatment has been effective, and for informing the patient and doctor if the cancer has returned, without the need for performing invasive biopsies.

“This is exciting work in the lung cancer space, and it’s hoped it will ease our patient’s journeys in a small way as they battle this deadly disease.” Dr Rose says.

This research is one of 23 exciting new research projects to share in the $1 million SALHN Enquiry Grant round, thanks to your generous support, and a collaboration between Flinders Foundation and The Hospital Research Foundation Group.